After settling with two groups of plaintiffs in an antitrust lawsuit last week, the drugmakers have now struck a deal with a clutch of retail pharmacy holdouts. This third deal resolves the wide-spanning case and allows the parties to avoid a jury trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,